NCT04199273

Brief Summary

Development and validation of a new affordable and easy-to-use phrenic nerve stimulation tool for diaphragm strength assessment in intensive care unit

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 9, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 13, 2019

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2022

Completed
Last Updated

September 16, 2022

Status Verified

September 1, 2022

Enrollment Period

2.8 years

First QC Date

December 9, 2019

Last Update Submit

September 15, 2022

Conditions

Keywords

Intensive Care UnitInvasive Mechanical VentilationDiaphragm weakness assessmentRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Tracheal pressure (Ptrach) during diaphragm pacing

    Negative pressure in the occluded breathing circuit, assessed with a manometer located just after the endotracheal tube, during diaphragm stimulation

    During electric of magnetic phrenic nerve stimulation

Secondary Outcomes (2)

  • Behavioral Pain Scale (BPS) after stimulation

    Immediately after phrenic nerve stimulation

  • Distance in millimeter between anatomical and ultrasound phrenic nerve location

    During ultrasonography phrenic nerve tracking

Study Arms (2)

Magnetic stimulation and electric stimulation

EXPERIMENTAL

The patient receive first the magnetic stimulation with MagStim 200 tool. Then 15 min after he will receive the electric stimulation with the SonoStim tool : ultrasonography phrenic nerve tracking and targeted electric stimulation with a nerve stimulator usually used for neuromuscular transmission monitoring (TOFScan, Drager)

Procedure: Magnetic stimulationProcedure: Electric stimulation

Electric stimulation and magnetic stimulation

EXPERIMENTAL

The patient receive first electric stimulation with the SonoStim tool : ultrasonography phrenic nerve tracking and targeted electric stimulation with a nerve stimulator usually used for neuromuscular transmission monitoring (TOFScan, Drager). Then 15 min after he will receive the magnetic stimulation with MagStim 200 tool

Procedure: Magnetic stimulationProcedure: Electric stimulation

Interventions

Cervical bilateral phrenic nerve stimulation with the MagStim 200 tool.

Electric stimulation and magnetic stimulationMagnetic stimulation and electric stimulation

Cervical bilateral phrenic nerve stimulation after ultrasonography nerve tracking and targeted electric stimulation with a nerve stimulator usually used for neuromuscular transmission monitoring (TOFScan, Drager)

Electric stimulation and magnetic stimulationMagnetic stimulation and electric stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ICU patient with invasive mechanical ventilation
  • Sedated patient with a Richmond Agitation-Sedation Scale of -4 or -5

You may not qualify if:

  • Contraindication for magnetic stimulation (Pacemaker)
  • Hemodynamic or respiratory instability : PaO2/FiO2 \< 200 mmHg, noradrenaline \> 0,3 µg/kg/min, dobutamine \> 10 µg/kg/min
  • Neuromuscular disease or recent use of neuromuscular blocking agents (2h30) with a TOF ratio below 4/4 95%.
  • Refusal of study participation or to pursue the study by the patient, no consent
  • Pregnancy or breastfeeding
  • Absence of coverage by the French statutory healthcare insurance system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire Saint Eloi

Montpellier, Herault, 34000, France

Location

Related Publications (1)

  • Capdevila M, De Jong A, Belafia F, Vonarb A, Carr J, Molinari N, Choquet O, Capdevila X, Jaber S. Ultrasound-guided Transcutaneous Phrenic Nerve Stimulation in Critically Ill Patients: A New Method to Evaluate Diaphragmatic Function. Anesthesiology. 2025 Mar 1;142(3):522-531. doi: 10.1097/ALN.0000000000005267. Epub 2024 Oct 21.

MeSH Terms

Interventions

Electric Stimulation

Intervention Hierarchy (Ancestors)

Physical StimulationInvestigative Techniques

Study Officials

  • Samir Jaber, MD, PHD

    Montpellier University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Each patient, serving as their own control, receives both types of phrenic nerve stimulation : magnetic stimulation and electric stimulation. The order is randomized. For avoid a carry-over effect (diaphragm potentiation), a wash-out period of 15 minutes will be respected between the two type of stimulation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2019

First Posted

December 13, 2019

Study Start

October 30, 2019

Primary Completion

August 25, 2022

Study Completion

August 25, 2022

Last Updated

September 16, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will share

Individual patient data will be made available upon a reasonable request

Shared Documents
STUDY PROTOCOL
Time Frame
12 months after the main publication
Access Criteria
Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and institutional review board (IRB) review. Dataset will be shared after careful examination by the study board of investigators.

Locations